Patients on Antipsychotics Report Disregarded Voices and Side Effects, Highlighting Flaws in Shared Decision-Making

A recent qualitative study sheds light on the distressing experiences of young adults prescribed antipsychotic medications, revealing a significant disconnect between the aspirational ideal of person-centered care and the reality faced by patients. Many individuals reported feeling unheard, dismissed, and lacking autonomy in their treatment journeys, particularly concerning the adverse effects of their medications. This research underscores the urgent need for systemic changes in psychiatric practice to genuinely integrate shared decision-making principles.

Antipsychotic Treatment: A Deep Dive into Patient Experiences and Healthcare Gaps

In a groundbreaking study published in the International Journal of Clinical Pharmacy in 2026, researchers Holly Grey and Laura Lindsey from Newcastle University, UK, explored the lived experiences of young adults receiving antipsychotic prescriptions. The study, drawing insights from 14 participants across the UK, US, and South Africa, highlighted critical deficiencies in current psychiatric care models. Participants, primarily aged 18 to 29, many of whom had been on antipsychotics for over a year, shared a consistent narrative of their concerns regarding side effects being overlooked and their voices marginalized.

Key findings from the study revealed several troubling themes. Firstly, the “Living with Antipsychotics” theme underscored the pervasive negative effects, including fatigue, dizziness, and weight gain, with some even reporting exacerbated psychosis and cardiovascular issues. Crucially, participants expressed profound frustration over healthcare professionals' failure to acknowledge or adequately address these concerns, often leading to a feeling of not being believed. One poignant account described a participant only being taken seriously after experiencing a severe physical reaction, highlighting a reactive rather than proactive approach to patient safety.

Secondly, the research illuminated the significant “Influence of Family and Friends,” where support systems, while often well-intentioned, inadvertently contributed to patients' lack of autonomy. Many participants felt excluded from discussions about their treatment, with decisions frequently made between clinicians and family members, leaving the patient feeling infantilized and disempowered. This dynamic further complicated the pursuit of genuine shared decision-making.

Thirdly, the theme of “Gaining Autonomy” revealed a mixed picture. While participants often resorted to independent research to understand their medications, their comprehension of shared decision-making varied widely. Many equated consent with shared decision-making, indicating a fundamental misunderstanding of its collaborative nature. Despite some progress towards greater involvement, full autonomy remained elusive for many, often conflated with mere access to medication.

Lastly, “Consequences of Young Adulthood” detailed the social repercussions of their diagnoses and treatments, including social exclusion and difficulties maintaining friendships. The demands of medication regimens and frequent appointments often interfered with normal social activities, further isolating these young individuals.

Despite limitations in sample size and generalizability due to recruitment methods, this study provides invaluable qualitative data, urging healthcare systems to prioritize genuine patient involvement, enhanced education, and robust training for professionals in shared decision-making. The authors advocate for collaborative efforts between service users and healthcare providers to develop resources that empower young adults in managing their care.

This study serves as a powerful reminder of the imperative to center the patient's voice in mental health treatment. It challenges the medical community to move beyond paternalistic approaches and embrace truly collaborative care, where informed consent is not just a formality but a lived experience. The emotional toll of being unheard, as highlighted by a participant's statement, “It's devastated me that I'm not being listened to,” demands immediate attention and systemic reform. Moving forward, the focus must shift from simply prescribing to truly understanding and partnering with patients, fostering an environment where their experiences, concerns, and preferences are not only heard but actively shape their care pathways.

Patients prescribed antipsychotics feel unheard: A call for shared decision-making
Patients prescribed antipsychotics feel unheard: A call for shared decision-making
A new study reveals that individuals prescribed antipsychotics often feel their concerns about negative effects are ignored, highlighting a significant gap in person-centered care and shared decision-making within psychiatry. Despite global advocacy for patient autonomy, many are not fully informed or involved in their treatment choices, leading to feelings of being unheard and undermining treatment adherence and satisfaction. The study underscores the urgent need for changes in clinical practice, including improved communication and comprehensive shared decision-making training for healthcare professionals.
learn more
Antidepressant Withdrawal: A Physician's Personal Journey and Research Insights
Antidepressant Withdrawal: A Physician's Personal Journey and Research Insights
Dr. Mark Horowitz, a psychiatrist and researcher, shares his personal experience with severe antidepressant withdrawal symptoms, which ignited his passion for studying the subject. His research, co-authored with Dr. David Taylor and published in *Lancet Psychiatry*, highlights the importance of slow, hyperbolic tapering off antidepressants over months or even years, rather than quick discontinuation, to prevent debilitating withdrawal effects. This interview delves into the neurobiology of withdrawal and the challenges within the medical community in acknowledging and addressing this critical issue, advocating for evidence-based guidelines.
learn more
Challenging Psychiatry's Low Expectations: A Journey of Resilience
Challenging Psychiatry's Low Expectations: A Journey of Resilience
This article explores the detrimental impact of low expectations imposed by the psychiatric system on individuals with mental health diagnoses. The author shares a personal experience of being dismissed by a social worker and the subsequent journey of recovery and academic success, far exceeding the initial prognosis. It also critiques media portrayals of mental illness and highlights similar experiences of other highly capable individuals who defied societal and institutional limitations.
learn more
The Neuro-Identitarian Predicament: Alienation in an Age of Diagnosis
This article critically examines the burgeoning trend of neurodiversity diagnoses, arguing that this phenomenon, while offering a sense of identity, paradoxically deepens societal alienation. It explores how the expansion of diagnostic categories for conditions like autism and ADHD may be a response to the pervasive feelings of inadequacy and misunderstanding fostered by late-stage capitalism, rather than purely neurological differences. The author suggests that relying on individual diagnoses to explain collective human distress diverts attention from the need for broader systemic change.
Challenging Psychiatry's Low Expectations for High Achievers
This article discusses the pervasive issue of low expectations set by the psychiatric system for individuals diagnosed with mental health conditions. Drawing on personal experiences and critical analyses of media portrayals and professional attitudes, it highlights how such biases, often disguised as kindness, can hinder recovery and suppress the potential of highly capable individuals. The piece advocates for a shift in societal and professional perspectives to foster environments that support flourishing rather than limiting potential based on diagnoses.
Gut Microbes: A New Culprit in Depression
Recent research has uncovered a significant link between gut microbes and major depressive disorder (MDD). While correlation doesn't always imply causation, a new study employing advanced statistical methods has identified two specific microbes, Eggerthella and Hungatella, as causal factors in depression. This discovery represents a breakthrough in understanding the gut-brain axis and could pave the way for novel treatments that target the microbiome to alleviate depressive symptoms.
The Dual Benefits of Consistent Exercise: Improved Mood and Restful Sleep
Two recent studies highlight the significant impact of consistent exercise on both mental well-being and sleep quality. They suggest that regular physical activity can lead to a more stable mood and more restful sleep, with these benefits occurring independently rather than one being a byproduct of the other. The research emphasizes that the key to reaping these rewards lies in consistency and intensity, rather than the specific type of exercise, underscoring exercise as a powerful tool for overall health.